299 related articles for article (PubMed ID: 12445380)
1. Squamous cell carcinoma of the colon with an elevated serum squamous cell carcinoma antigen responding to combination chemotherapy.
Copur S; Ledakis P; Novinski D; Mleczko KL; Frankforter S; Bolton M; Fruehling RM; VanWie E; Norvell M; Muhvic J
Clin Colorectal Cancer; 2001 May; 1(1):55-8. PubMed ID: 12445380
[TBL] [Abstract][Full Text] [Related]
2. [The course of squamous cell carcinoma antigen and CEA as prognostic criteria for response to chemotherapy in cervix cancer].
Meier W; Eiermann W; Stieber P; Fateh-Moghadam A; Hepp H
Geburtshilfe Frauenheilkd; 1989 Dec; 49(12):1050-5. PubMed ID: 2693187
[TBL] [Abstract][Full Text] [Related]
3. Docetaxel, cisplatin, and fluorouracil for patients with inoperable recurrent or metastatic head and neck squamous cell carcinoma.
Cho H; Nishiike S; Yamamoto Y; Takenaka Y; Nakahara S; Yasui T; Hanamoto A; Inohara H
Auris Nasus Larynx; 2015 Oct; 42(5):396-400. PubMed ID: 25721854
[TBL] [Abstract][Full Text] [Related]
4. Preoperative SCC-Ag as a predictive marker for the use of adjuvant chemotherapy in cervical squamous cell carcinoma with intermediate-risk factors.
Guo HT; Bi XH; Lei T; Lv X; Yao G; Chen Y; Liu C
BMC Cancer; 2020 May; 20(1):441. PubMed ID: 32429859
[TBL] [Abstract][Full Text] [Related]
5. The predictive value of serum squamous cell carcinoma antigen in patients with cervical cancer who receive neoadjuvant chemotherapy followed by radical surgery: a single-institute study.
Li X; Zhou J; Huang K; Tang F; Zhou H; Wang S; Jia Y; Sun H; Ma D; Li S
PLoS One; 2015; 10(4):e0122361. PubMed ID: 25860888
[TBL] [Abstract][Full Text] [Related]
6. Squamous-cell carcinoma of the colon responsive to combination chemotherapy: report of two cases and review of the literature.
Juturi JV; Francis B; Koontz PW; Wilkes JD
Dis Colon Rectum; 1999 Jan; 42(1):102-9. PubMed ID: 10211528
[TBL] [Abstract][Full Text] [Related]
7. The value of squamous cell carcinoma antigen in patients with locally advanced cervical cancer undergoing neoadjuvant chemotherapy.
Scambia G; Panici PB; Baiocchi G; Amoroso M; Foti E; Greggi S; Mancuso S
Am J Obstet Gynecol; 1991 Feb; 164(2):631-6. PubMed ID: 1992715
[TBL] [Abstract][Full Text] [Related]
8. Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with early-stage cervical cancer.
Esajas MD; Duk JM; de Bruijn HW; Aalders JG; Willemse PH; Sluiter W; Pras B; ten Hoor K; Hollema H; van der Zee AG
J Clin Oncol; 2001 Oct; 19(19):3960-6. PubMed ID: 11579117
[TBL] [Abstract][Full Text] [Related]
9. [Combination chemotherapy with ifosfamide, 5-fuluorouracil, etoposide and cisplatin for advanced urothelial cancer: the treatment results and significance of tumor marker evaluation in response assessment of chemotherapy].
Maezawa T; Yonese J; Tsukamoto T; Ishii N; Fukui I
Nihon Hinyokika Gakkai Zasshi; 2002 Nov; 93(7):727-35. PubMed ID: 12494517
[TBL] [Abstract][Full Text] [Related]
10. [Diagnosis of recurrences of head and neck carcinoma with the tumor marker SSC-antigen].
Arlt A; Luckhaupt H; Hildmann H
Laryngorhinootologie; 2000 Apr; 79(4):207-12. PubMed ID: 10838684
[TBL] [Abstract][Full Text] [Related]
11. Squamous cell carcinoma antigen (SCC-Ag) during follow-up of cervical cancer patients: Role in the early diagnosis of recurrence.
Salvatici M; Achilarre MT; Sandri MT; Boveri S; Vanna Z; Landoni F
Gynecol Oncol; 2016 Jul; 142(1):115-119. PubMed ID: 27117922
[TBL] [Abstract][Full Text] [Related]
12. [The course of squamous cell cancer antigen in chemotherapy as a prognostic criterion in cervix cancer].
Meier W; Stieber P; Fateh-Moghadam A; Eiermann W; Hepp H
Gynakol Rundsch; 1989; 29 Suppl 2():411-2. PubMed ID: 2613066
[No Abstract] [Full Text] [Related]
13. Second-line combination chemotherapy with docetaxel and nedaplatin for Cisplatin-pretreated refractory metastatic/recurrent esophageal squamous cell carcinoma.
Jin J; Xu X; Wang F; Yan G; Liu J; Lu W; Li X; Tucker SJ; Zhong B; Cao Z; Wang D
J Thorac Oncol; 2009 Aug; 4(8):1017-21. PubMed ID: 19542899
[TBL] [Abstract][Full Text] [Related]
14. Serum concentrations of squamous-cell carcinoma antigen and tissue polypeptide antigen in the follow-up of patients with vulvar cancer.
Hefler L; Frischmuth K; Heinze G; Sliutz G; Leodolter S; Reinthaller A; Kainz C; Tempfer C
Int J Cancer; 1999 Oct; 83(2):167-70. PubMed ID: 10471522
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of serum SCC Ag in patients with squamous cell carcinoma of the lung].
Zeng L
Zhonghua Wai Ke Za Zhi; 1993 Mar; 31(3):143-5. PubMed ID: 8223022
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy as initial treatment for cervical carcinoma: clinical and tumor marker response.
Leminen A; Alftan H; Stenman UH; Lehtovirta P
Acta Obstet Gynecol Scand; 1992 May; 71(4):293-7. PubMed ID: 1322623
[TBL] [Abstract][Full Text] [Related]
17. Squamous cell carcinoma antigen in oral squamous cell carcinomas.
Nagumo K; Okada N; Takagi M; Yamamoto H; Amagasa T; Fujibayashi T
Bull Tokyo Med Dent Univ; 1990 Jun; 37(1-2):27-34. PubMed ID: 2225283
[TBL] [Abstract][Full Text] [Related]
18. Squamous cell carcinoma antigen, circulating immune complexes, and immunoglobulins in monitoring squamous cell carcinoma of head and neck: a study of the hellenic co-operative oncology group (HeCOG).
Makrantonakis P; Pectasides D; Aggouridakis C; Visvikis A; Daniilidis J; Fountzilas G
Am J Clin Oncol; 1999 Dec; 22(6):542-9. PubMed ID: 10597736
[TBL] [Abstract][Full Text] [Related]
19. Squamous cell carcinoma of the colon - a case report.
Jurišová S; Angelis De V; Makovník M; Hlavčák P; Janega P; Macák D; Chovanec M; Rejleková K; Pinďák D; Mardiak J; Mego M
Klin Onkol; 2020; 33(5):380-384. PubMed ID: 33108883
[TBL] [Abstract][Full Text] [Related]
20. [Relevance of the new tumor marker SCC (squamous cell carcinoma antigen) for the diagnosis and follow-up control of squamous epithelial carcinoma of the head and neck].
Koch T; Eiffert H; Spindler MB
HNO; 1989 Nov; 37(11):454-9. PubMed ID: 2584067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
